Agios Pharmaceuticals Inc (NASDAQ:AGIO)

86.45
Delayed Data
As of Apr 20
 -1.84 / -2.08%
Today’s Change
45.11
Today|||52-Week Range
89.33
+51.22%
Year-to-Date

Today’s Trading

Previous close88.29
Today’s open87.76
Day’s range85.65 - 88.30
Volume572,722
Average volume (3 months)546,899
Market cap$4.8B
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)-33.14%
Earnings growth (this year)+7.32%
Earnings growth (next 5 years)--
Revenue growth (last year)-38.46%
P/E ratioNM
Price/Sales61.92
Price/Book10.92

Competitors

 Today’s
change
Today’s
% change
HCMHutchison China Medi...-0.70-2.08%
SAGESAGE Therapeutics In...-21.66-12.77%
ICPTIntercept Pharmaceut...-0.50-0.72%
LGNDLigand Pharmaceutica...-1.62-0.96%
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateMay 10, 2018
EPS forecast (this quarter)-$1.79
Annual revenue (last year)$43.0M
Annual profit (last year)-$314.7M
Net profit margin-731.60%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David Paul Schenkein
CFO &
Head-Corporate Development
Andrew J. Hirsch
Corporate headquarters
Cambridge, Massachusetts

Forecasts